Plasma Membrane Proteomics Identifies Biomarkers Associated with T(4;14) Multiple Myeloma

被引：0
|
作者：
Xie, Zhigang [1 ]
Gunaratne, Jayantha
Cheong, Lip Lee
Liu, Shaw Cheng [1 ]
Koh, Tze Loong
Huang, Gaofeng
Blackstock, Walter
Chng, Wee-Joo
机构：
[1] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1314.1314
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1314
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Arabidopsis plasma membrane proteomics identifies components of transport, signal transduction and membrane trafficking
    Alexandersson, E
    Saalbach, G
    Larsson, C
    Kjellbom, P
    PLANT AND CELL PHYSIOLOGY, 2004, 45 (11) : 1543 - 1556
  • [22] Clinical and biological features of t(4;14) multiple myeloma: a prospective study
    Karlin, Lionel
    Soulier, Jean
    Chandesris, Olivia
    Choquet, Sylvain
    Belhadj, Karim
    Macro, Margaret
    Bouscary, Didier
    Porcher, Raphael
    Ghez, David
    Malphettes, Marion
    Asli, Bouchra
    Brouet, Jean Claude
    Bories, Jean Christophe
    Hermine, Olivier
    Fermand, Jean Paul
    Arnulf, Bertrand
    LEUKEMIA & LYMPHOMA, 2011, 52 (02) : 238 - 246
  • [23] Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution
    A K Stewart
    H Chang
    S Trudel
    K C Anderson
    P Richardson
    M Alsina
    D Reece
    S Young
    A Sable-Hunt
    Z Li
    J Keats
    S Van Wier
    G Ahmann
    T Price-Troska
    K Giusti
    P L Bergsagel
    M Chesi
    R Fonseca
    Leukemia, 2007, 21 : 2358 - 2359
  • [24] The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
    Joseph Longo
    Petr Smirnov
    Zhihua Li
    Emily Branchard
    Jenna E. van Leeuwen
    Jonathan D. Licht
    Benjamin Haibe-Kains
    David W. Andrews
    Jonathan J. Keats
    Trevor J. Pugh
    Suzanne Trudel
    Linda Z. Penn
    Leukemia, 2021, 35 : 796 - 808
  • [25] Translocation t(4; 14) and multiple myeloma : is it a new independent prognostic factor?
    Manier, Salomon
    Leleu, Xavier
    HEMATOLOGIE, 2011, 17 (01): : 17 - 17
  • [26] Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution
    Stewart, A. K.
    Chang, H.
    Trudel, S.
    Anderson, K. C.
    Richardson, P.
    Alsina, M.
    Reece, D.
    Young, S.
    Sable-Hunt, A.
    Li, Z.
    Keats, J.
    Van Wier, S.
    Ahmann, G.
    Price-Troska, T.
    Giusti, K.
    Bergsagel, P. L.
    Chesi, M.
    Fonseca, R.
    LEUKEMIA, 2007, 21 (11) : 2358 - 2359
  • [27] The snoRNA target of t(4;14) in multiple myeloma regulates ribosome biogenesis
    Oliveira, Vanessa
    Mahajan, Nitin
    Bates, Melissa L.
    Tripathi, Chakrapani
    Kim, Kyusik Q.
    Zaher, Hani S.
    Maggi, Leonard B., Jr.
    Tomasson, Michael H.
    FASEB BIOADVANCES, 2019, 1 (07) : 404 - 414
  • [28] FGFR3 expression correlates with the presence of t(4;14) in multiple myeloma and is not seen is normal plasma cells
    Ely, SA
    Ely, SA
    Knowles, DM
    Bergsagel, PL
    LABORATORY INVESTIGATION, 2002, 82 (01) : 239A - 239A
  • [29] FGFR3 expression correlates with the presence of t(4;14) in multiple myeloma and is not seen is normal plasma cells
    Ely, SA
    Ely, SA
    Knowles, DM
    Bergsagel, PL
    MODERN PATHOLOGY, 2002, 15 (01) : 239A - 239A
  • [30] Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma
    Sonia M. Setayesh
    Libere J. Ndacayisaba
    Kate E. Rappard
    Valerie Hennes
    Luz Yurany Moreno Rueda
    Guilin Tang
    Pei Lin
    Robert Z. Orlowski
    David E. Symer
    Elisabet E. Manasanch
    Stephanie N. Shishido
    Peter Kuhn
    npj Precision Oncology, 7
12345